IDEX (NYSE:IEX) Stock, Quote.Headers.trade-ideas

IDEX

Idex manufactures pumps, flow meters, valves, and fluidic systems for customers in a variety of end markets, including industrial, fire and safety, life science, and water. The firm's business is organized into three segments: fluid and metering technologies, health and science technologies, and fire and safety and diversified products. Based in Lake Forest, Illinois, Idex has manufacturing operations in over 20 countries and has over 7,000 employees. The company generated $3.3 billion in revenue in 2023.

Earnings

Earnings Beats

News

Markets

Analyst Ratings

Trading Ideas

IDEX Corporation&#39;s (NYSE: IEX) second-quarter 2024 adjusted earnings of $2.06 per share surpassed the Zacks Consensus Estimate of $2.04. The bottom line decreased approximately 6% from the year-ago quarter&#39;s earnings of $2.18 per share.

IDEX Q2 Earnings Top Estimates, Sales Miss, &#39;24 View Down

Price Target

Small Cap

ALLY

CRTO

MEOH

PAYC

RBLX

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Disney To Rally Over 26%? Here Are 10 Top Analyst Forecasts For Thursday

Movers

IDEX (NYSE: IEX) shares are trading lower after the company reported Q4 results and issued Q1 adjusted EPS guidance below estimates.

Why IDEX Shares Are Trading Lower Today

IDEX Corp

iExalt Inc

iExec RLC - United States Dollar

IDEX's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>) short percent of float has risen 13.45% since its last report. The company recently reported that it has 898 thousand shares sold short, which is 1.35% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.53 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>IDEX Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1725556515_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for IDEX has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing IDEX's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, IDEX's peer group average for short interest as a percentage of float is 2.52%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

(IEX) - Analyzing IDEX's Short Interest

IDEX's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>) short percent of float has fallen 16.2% since its last report. The company recently reported that it has 793 thousand shares sold short, which is 1.19% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.66 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>IDEX Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1723815012_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for IDEX has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing IDEX's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, IDEX's peer group average for short interest as a percentage of float is 2.55%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About IDEX?

Argus Research analyst John Eade downgrades IDEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>) from Buy to Hold.

Downgrades

Argus Research Downgrades IDEX to Hold

Offerings

IDEX Corporation Prices $500M Public Offering Of 4.950% Senior Notes Due 2029; Expected To Close On August 21, 2024

TD Cowen analyst Joseph Giordano maintains IDEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>) with a Buy and lowers the price target from $240 to $230.

TD Cowen Maintains Buy on IDEX, Lowers Price Target to $230

IDEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>) has outperformed the market over the past 20 years by 3.72% on an annualized basis producing an average annual return of 11.98%. Currently, IDEX has a market capitalization of $14.54 billion. 
Buying $1000 In IEX: If an investor had bought $1000 of IEX stock 20 years ago, it would be worth $9,972.45 today based on a price of $192.12 for IEX at the time of writing.
<h3>IDEX's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1723041032_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In IDEX 20 Years Ago Would Be Worth Today

DA Davidson analyst Matt Summerville maintains IDEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>) with a Neutral and lowers the price target from $220 to $210.

DA Davidson Maintains Neutral on IDEX, Lowers Price Target to $210

4 analysts have shared their evaluations of IDEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $237.75, along with a high estimate of $241.00 and a low estimate of $236.00. A decline of 6.4% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2024/1722891626_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
A comprehensive examination of how financial experts perceive IDEX is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Bryan Blair</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$238.00</td>
<td>$245.00</td>
</tr>
<tr>
<td>Deane Dray</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$236.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>Michael Halloran</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$241.00</td>
<td>$256.00</td>
</tr>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$236.00</td>
<td>$265.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to IDEX. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of IDEX compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of IDEX's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of IDEX's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/IEX/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on IDEX analyst ratings.</a>
<h2>Discovering IDEX: A Closer Look</h2>
Idex manufactures pumps, flow meters, valves, and fluidic systems for customers in a variety of end markets, including industrial, fire and safety, life science, and water. The firm's business is organized into three segments: fluid and metering technologies, health and science technologies, and fire and safety and diversified products. Based in Lake Forest, Illinois, Idex has manufacturing operations in over 20 countries and has over 7,000 employees. The company generated $3.3 billion in revenue in 2023.
<h3>IDEX: Financial Performance Dissected</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Negative Revenue Trend: Examining IDEX's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately -4.61% in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 17.51%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): IDEX's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 3.89%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): IDEX's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 2.4%, the company showcases efficient use of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.36.
<h2>Analyst Ratings: Simplified</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Unveiling 4 Analyst Insights On IDEX

Oppenheimer analyst Bryan Blair maintains IDEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>) with a Outperform and lowers the price target from $245 to $238.

Oppenheimer Maintains Outperform on IDEX, Lowers Price Target to $238

RBC Capital analyst Deane Dray maintains IDEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>) with a Outperform and lowers the price target from $250 to $236.

RBC Capital Maintains Outperform on IDEX, Lowers Price Target to $236

Baird analyst Michael Halloran maintains IDEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>) with a Outperform and lowers the price target from $256 to $241.

Baird Maintains Outperform on IDEX, Lowers Price Target to $241

WIIM

IDEX shares are trading lower after the company reported worse-than-expected Q2 earnings and FY Adjusted EPS guidance.

IDEX Corporation&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iex#NYSE">IEX</a>) second-quarter 2024 adjusted earnings of $2.06 per share surpassed the Zacks Consensus Estimate of $2.04. The bottom line decreased approximately 6% from the year-ago quarter&#39;s earnings of $2.18 per share. However, it exceeded management&#39;s projection of $2.00-$2.05 per share.
<h3>Revenue Details</h3>
IDEX&#39;s net sales of $807.2 million missed the Zacks Consensus Estimate of $831 million.&nbsp; The top line also decreased 5% year over year. Organic sales decreased 4% year over year. Foreign currency translation had a negative impact on sales by 1%.
IEX reports net sales under three business segments, the results of which are discussed below:
Net sales from the Fluid &amp; Metering Technologies segment totaled $319.4 million, down 2% year over year. Our estimate for segmental net sales was $327 million. While organic sales were flat year over, acquisition/divestitures and foreign currency translation each had a negative impact of 1% on sales.
Net sales from the Health &amp; Science Technologies segment totaled $303.8 million, indicating a year-over-year decline of 11%. Our estimate for segmental net sales was $321 million. Organic sales declined 11% year over year.
Net sales from the Fire &amp; Safety/Diversified Products segment totaled $185.4 million, which increased marginally year over year. Our estimate for segmental net sales was $185 million. Organic sales increased 1% on a year-over-year basis while foreign currency translation hurt sales by 1%.
<div class="chart_embed">
<h3>IDEX Corporation Price, Consensus and EPS Surprise</h3>
<img alt="IDEX Corporation Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/43/1722510887.png" style="height:265px; width:583px" title="" />
IDEX Corporation price-consensus-eps-surprise-chart | IDEX Corporation Quote
</div>
<h3>Margin Profile</h3>
IDEX&#39;s cost of sales decreased 5.9% year over year to $440.4 million. The gross profit was $366.8 million, down 3% year over year. The gross margin was 45.4% compared with 44.7% in the year-ago quarter.
Selling, general and administrative expenses increased 4.9% year over year to $182.8 million. Adjusted EBITDA decreased 6.9% year over year to $224.2 million. The adjusted EBITDA margin decreased 60 bps year over year to 27.8%.
The operating income was $182.7 million, down 8.7% year over year. The operating margin was 22.6%, down 100 bps year over year. Interest expenses (net) decreased 39.1% year over year to $8.1 million.
<h3>Balance Sheet and Cash Flow</h3>
While exiting the second quarter, IDEX&#39;s cash and cash equivalents were $700.7 million compared with $534.3 million at the end of fourth-quarter 2023. Long-term borrowings (net) were $1.30 billion compared with $1.33 billion at the end of fourth-quarter 2023.
In the first six months of 2024, IDEX generated net cash of $290.2 million from operating activities, up 0.4% from the year-ago period. Capital expenditures were $35.9 million compared with $48.2 million in the first six months of 2023. In the same period, free cash flow was $254.3 million, up 5.5% year over year.
Idex paid out dividends totaling $100.7 million in the first six months of 2024, up 7.2% year over year.
<h3>Outlook</h3>
For the third quarter, IDEX anticipates adjusted earnings to be in the band of $1.85-$1.90 per share.
On a GAAP basis, IEX predicts earnings to be in the range of $1.61-$1.66 per share and a 0-1% increase in organic sales from the respective year-ago readings.
For 2024, IDEX anticipates adjusted earnings to be $7.80-$7.90 per share, down from the earlier projected range of $8.15 - $8.45. The figure indicates a decrease from earnings of $8.22 per share reported in 2023. On a GAAP basis, earnings are predicted to be $6.85-$6.95 per share, down from the earlier guided range of $7.13-$7.43.
Organic sales are predicted to decline 1-2% compared with the 0-2% decline guided earlier.
<h3>Zacks Rank &amp; Stocks to Consider</h3>
IDEX currently carries a Zacks Rank #4 (Sell). Some better-ranked companies from the Industrial Products sector have been discussed below:
Kadant Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kai#NYSE">KAI</a>) presently sports a Zacks Rank #1 (Strong Buy).
It has a trailing four-quarter average earnings surprise of 18%.
The Zacks Consensus Estimate for KAI&#39;s 2024 earnings has increased 0.2% in the past 60 days.
Flowserve Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fls#NYSE">FLS</a>) currently carries a Zacks Rank #2 (Buy). FLS delivered a trailing four-quarter average earnings surprise of 18.2%.
In the past 60 days, the consensus estimate for Flowserve&#39;s 2024 earnings has increased 0.8%.
Emerson Electric Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/emr#NYSE">EMR</a>) presently carries a Zacks Rank of 2. The company delivered a trailing four-quarter average earnings surprise of 10.7%.
In the past 60 days, the Zacks Consensus Estimate for EMR&#39;s 2024 earnings has increased 0.4%.
<a href="https://www.zacks.com/stock/news/2313904/idex-iex-q2-earnings-top-estimates-sales-miss-24-view-down?cid=CS-BENZ-FT-analyst_blog|earnings_article-2313904">To read this article on Zacks.com click here.</a>

IDEX Q2 Earnings Top Estimates, Sales Miss, '24 View Down

Guidance

IDEX Expects Q3 Organic Sales To Be Up 0% To 1%, Adjusted EPS Of $1.85 - $1.90 (Est $2.19)

IDEX Cuts FY24 Adjusted EPS Forecast From $8.15 - $8.45 To $7.80 - $7.90, Est $8.29

IDEX Expects FY24 Organic Sales Growth To Decline 1% - 2% Y/Y, Down From Previous Guidance Of An Increase Of 0% - 2%

IDEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>) reported quarterly earnings of $2.06 per share which beat the analyst consensus estimate of $2.04 by 0.98 percent. This is a 5.5 percent decrease over earnings of $2.18 per share from the same period last year. The company reported quarterly sales of $807.200 million which missed the analyst consensus estimate of $827.785 million by 2.49 percent. This is a 4.61 percent decrease over sales of $846.200 million the same period last year.

Earnings Misses

IDEX Q2 2024 Adj. EPS $2.06 Beats $2.04 Estimate, Sales $807.200M Miss $827.785M Estimate

IDEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>) has outperformed the market over the past 15 years by 2.11% on an annualized basis producing an average annual return of 14.22%. Currently, IDEX has a market capitalization of $15.43 billion. 
Buying $1000 In IEX: If an investor had bought $1000 of IEX stock 15 years ago, it would be worth $7,469.49 today based on a price of $203.90 for IEX at the time of writing.
<h3>IDEX's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1721829630_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In IDEX 15 Years Ago Would Be Worth This Much Today

Stifel analyst Nathan Jones maintains IDEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>) with a Buy and lowers the price target from $265 to $236.

Stifel Maintains Buy on IDEX, Lowers Price Target to $236

IDEX's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEX#NYSE">IEX</a>) short percent of float has risen 17.48% since its last report. The company recently reported that it has 1.12 million shares sold short, which is 1.68% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>IDEX Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1720715411_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for IDEX has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing IDEX's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, IDEX's peer group average for short interest as a percentage of float is 3.38%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Peering Into IDEX's Recent Short Interest

Argus Research analyst John Eade maintained a Hold rating on IDEX (IEX – Research Report) yesterday. The company's shares closed yesterday at $194....

IDEX (IEX) Receives a Rating Update from a Top Analyst

The 28 companies in BMO Capital's high-quality stock screen

Graco: A Shareholder-Oriented Compounder

IDEX Corp. Q2: Project Delay And Weakness In Life Science

35 "green" energy stocks for a new era of profitability - Citi

Ecolab and IDEX – new additions to the clean water theme for Citi's Thematic 30

IDEX ( ($IEX) ) has provided an update. IDEX Corporation has successfully completed the acquisition of Mott Corporation, integrating Mott's experti...

IDEX Enhances Tech Portfolio with Mott Corporation Acquisition

In a report released today, Joseph C Giordano from TD Cowen maintained a Buy rating on IDEX (IEX – Research Report), with a price target of $230.00...

TD Cowen Remains a Buy on IDEX (IEX)

IDEX declares $0.69 dividend

How four election outcomes could impact the markets, according to Société Générale

ALLE

AMBP

AMGN

AQWA

ARIS

BALL

BFAM

BWXT

CBOE

COIN

CSCO

CTAS

ENPH

ERII

FELE

FERG

GOOGL

HTLD

ICLN

LRCX

MSFT

NDSN

PANW

PCAR

PESI

QCLN

QQQM

SEDG

SHLS

SRCL

STLD

STRL

TSLA

VLTO

Press Releases

Tony Satterthwaite Retiring After Distinguished Career at Cummins

Chemours Names Tony Satterthwaite to Board of Directors

IDEX Corporation Declares Regular Quarterly Cash Dividend

IDEX Corporation to Webcast Second Quarter 2024 Earnings Call

IDEX Corporation to Acquire Mott Corporation, Expanding Applied Materials Science Technology Capabilities Across High-Value End Markets

IDEX Reports Second Quarter Results and Updates 2024 Outlook

IDEX Corporation Announces Pricing of Public Offering of Senior Notes

Amprius Appoints Transportation Industry Veteran Tony Satterthwaite to Board of Directors

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

IDEX

IDEX (IEX) Forecast

IDEX (NYSE:IEX) Stock, Quote.Headers.trade-ideas